Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution
Prihantono
Surgery Open Science
Q2Published: 2023Citations: 3
Abstract
Generally, the response to NAC in breast cancer was very good. The DFS rates were significantly different from the chemotherapy response but not from the NAC regimen.
Access to Document
10.1016/j.sopen.2023.07.016Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
MedicineSciences
Breast cancerSciences
Internal medicineSciences
OncologySciences
ChemotherapySciences
RegimenSciences
MalignancySciences
Survival rateSciences
CancerSciences
SurgerySciences